glp-1 nausea attorney in louisiana RA Lawsuit - Shreveport Lawyer Patients claim blindness, bowel injuries

Watkins, S., & Maes, D

Retrieved from Centers for Disease Control and Prevention

We flag it only to be complete and honest about where the science actually stands, because responsible information means clearly separating what is proven from what is still being studied

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, has emerged as a significant complication of pediatric obesity

The Bottom Line GLP-1 receptor agonist medications are changing lives for many people, but they also change the way the digestive system works and, for many users, reduce the dietary fiber and nutrient diversity that a healthy gut microbiome depends on